Consultation: Electronic media in prescription drug labelling draft guidance document

From Health Canada

Current status: Closed

This consultation ran from March 12, 2021 to May 7, 2021.

Comments were requested on the draft guidance.

Who was the focus of this consultation

Health Canada engaged with:

• industry
• health professionals
• other interested parties

Contact us

Bureau of Policy, Science and International Programs
Therapeutic Products Directorate
Health Canada
1600 Scott Street
Holland Cross, Tower B
2nd Floor, Address Locator 3102C5
Ottawa, Ontario
K1A 0K9
E-mail: hc.policy.bureau.enquiries.sc@canada.ca